The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries
出版年份 2017 全文链接
标题
The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Volume 138, Issue -, Pages 47-56
出版商
Wiley
发表日期
2017-07-10
DOI
10.1002/ijgo.12184
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings
- (2017) Nicole G. Campos et al. INTERNATIONAL JOURNAL OF CANCER
- Development assistance for health: past trends, associations, and the future of international financial flows for health
- (2016) Joseph L Dieleman et al. LANCET
- Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries
- (2016) Nicole G. Campos et al. PLoS One
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador
- (2015) Nicole G. Campos et al. INTERNATIONAL JOURNAL OF CANCER
- Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage
- (2015) Nicole G. Campos et al. INTERNATIONAL JOURNAL OF CANCER
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters
- (2014) Nicole G. Campos et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- In Reply to Sharma et al
- (2014) Niloy R. Datta et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
- (2014) Mark Jit et al. Lancet Global Health
- Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
- (2011) Barbara Romanowski et al. Human vaccines & immunotherapeutics
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Expansion of cancer care and control in countries of low and middle income: a call to action
- (2010) Paul Farmer et al. LANCET
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Cancer survival in Africa, Asia, and Central America: a population-based study
- (2009) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
- (2008) Sue J. Goldie et al. VACCINE
- Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
- (2008) Rolando Herrero et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started